JMJD8 Functions as a Novel AKT1 Lysine Demethylase

被引:5
|
作者
Wang, Yujuan [1 ]
Zhang, Yaoyao [1 ,2 ]
Li, Zehua [1 ,2 ]
Wang, Junfeng [1 ,3 ]
机构
[1] Chinese Acad Sci, Hefei Inst Phys Sci, High Magnet Field Lab, CAS Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Peoples R China
[2] Univ Sci & Technol China, Grad Sch, Sci Isl Branch, Hefei 230026, Peoples R China
[3] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Peoples R China
基金
中国国家自然科学基金;
关键词
JMJD8; demethylase; AKT1; tri-methylated lysine; JmjC domain; HISTONE; FAMILY;
D O I
10.3390/ijms24010460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
JMJD8 is a protein from the JMJD family that only has the JmjC domain. Studies on the function of JMJD8 indicate that JMJD8 is involved in signaling pathways, including AKT/NF-kappa B, and thus affects cell proliferation and development. Here, we reported the activity of JMJD8 as a non-histone demethylase. We investigated the demethylation of JMJD8 on trimethylated lysine of AKT1 in vivo and in vitro using trimethylated AKT1 short peptide and AKT1 protein, and we tracked the regulation of JMJD8 on AKT1 activity at the cellular level. The results showed that JMJD8, a mini lysine demethylase, altered AKT1 protein function via changing its degree of methylation.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] JMJD8 is a novel endoplasmic reticulum protein with a JmjC domain
    Kok Siong Yeo
    Ming Cheang Tan
    Yat-Yuen Lim
    Chee-Kwee Ea
    Scientific Reports, 7
  • [2] JMJD8 is a novel endoplasmic reticulum protein with a JmjC domain
    Yeo, Kok Siong
    Tan, Ming Cheang
    Lim, Yat-Yuen
    Ea, Chee-Kwee
    SCIENTIFIC REPORTS, 2017, 7
  • [3] JMJD8 Is a Novel Molecular Nexus Between Adipocyte-Intrinsic Inflammation and Insulin Resistance
    You, Dongjoo
    Jung, Byung Chul
    Villivalam, Sneha Damal
    Lim, Hee-Woong
    Kang, Sona
    DIABETES, 2022, 71 (01) : 43 - 59
  • [4] Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial–mesenchymal transition
    Yao Su
    Xueying Wang
    Zhen Guo
    Jun Wang
    Oncogene, 2020, 39 : 6451 - 6467
  • [5] Correction: Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial–mesenchymal transition
    Yao Su
    Xueying Wang
    Zhen Guo
    Jun Wang
    Oncogene, 2021, 40 : 3180 - 3186
  • [6] Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition
    Su, Yao
    Wang, Xueying
    Guo, Zhen
    Wang, Jun
    ONCOGENE, 2020, 39 (41) : 6451 - 6467
  • [7] JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
    Zhang, Bo
    Zhang, Yao
    Jiang, Xizi
    Su, Hongbo
    Wang, Qiongzi
    Wudu, Muli
    Jiang, Jun
    Ren, Hongjiu
    Xu, Yitong
    Liu, Zongang
    Qiu, Xueshan
    JOURNAL OF CANCER, 2021, 12 (04): : 976 - 987
  • [8] Vimentin is a novel AKT1 target mediating motility and invasion
    Zhu, Q-S
    Rosenblatt, K.
    Huang, K-L
    Lahat, G.
    Brobey, R.
    Bolshakov, S.
    Nguyen, T.
    Ding, Z.
    Belousov, R.
    Bill, K.
    Luo, X.
    Lazar, A.
    Dicker, A.
    Mills, G. B.
    Hung, M-C
    Lev, D.
    ONCOGENE, 2011, 30 (04) : 457 - 470
  • [9] Proteus syndrome caused by novel somatic AKT1 duplication
    AlAnzi, Talal
    Al-mashharawi, Eman
    Alhashem, Amal
    SAUDI MEDICAL JOURNAL, 2021, 42 (01) : 95 - 99
  • [10] Antitumor Activity of a Novel Antisense Oligonucleotide Against Akt1
    Yoon, Heejeong
    Kim, Deog Joong
    Ahn, Eun Hyun
    Gellert, Ginelle C.
    Shay, Jerry W.
    Ahn, Chang-Ho
    Lee, Young Bok
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (04) : 832 - 838